Cardiovascular Effects of GLP-1 Receptor Activation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Obesity
- Prediabetes
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Treatment with liraglutide or sitagliptin will be masked using matching placebo.Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03101930
- Collaborators
- American Heart Association
- Investigators
- Principal Investigator: James M. Luther, M.D. Vanderbilt University Medical Center
Get Well Soon